Heteroplasmy and Copy Number in the Common m.3243A>G Mutation—A Post-Mortem Genotype–Phenotype Analysis

Different mitochondrial DNA (mtDNA) mutations have been identified to cause mitochondrial encephalopathy, lactate acidosis and stroke-like episodes (MELAS). The underlying genetic cause leading to an enormous clinical heterogeneity associated with m.3243A>G-related mitochondrial diseases is still poorly understood. Genotype–phenotype correlation (heteroplasmy levels and clinical symptoms) was analysed in 16 patients (15 literature cases and one unreported case) harbouring the m.3243A>G mutation. mtDNA copy numbers were correlated to heteroplasmy levels in 30 different post-mortem tissue samples, including 14 brain samples of a 46-year-old female. In the central nervous system, higher levels of heteroplasmy correlated significantly with lower mtDNA copy numbers. Skeletal muscle levels of heteroplasmy correlated significantly with kidney and liver. There was no significant difference of heteroplasmy levels between clinically affected and unaffected patients. In the patient presented, we found >75% heteroplasmy levels in all central nervous system samples, without harbouring a MELAS phenotype. This underlines previous suggestions, that really high levels in tissues do not automatically lead to a specific phenotype. Missing significant differences of heteroplasmy levels between clinically affected and unaffected patients underline recent suggestions that there are additional factors such as mtDNA copy number and nuclear factors that may also influence disease severity.

[1]  A. Pajak,et al.  Modulation of mtDNA copy number ameliorates the pathological consequences of a heteroplasmic mtDNA mutation in the mouse , 2019, Science Advances.

[2]  D. Mari,et al.  Quantitative mitochondrial DNA copy number determination using droplet digital PCR with single-cell resolution , 2019, Genome Research.

[3]  Robert W. Taylor,et al.  mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease , 2018, EMBO molecular medicine.

[4]  Robert W. Taylor,et al.  Phenotypic heterogeneity in m.3243A>G mitochondrial disease: The role of nuclear factors , 2018, Annals of clinical and translational neurology.

[5]  Robert W. Taylor,et al.  A novel m.7539C>T point mutation in the mt-tRNAAsp gene associated with multisystemic mitochondrial disease , 2015, Neuromuscular Disorders.

[6]  Robert W. Taylor,et al.  Accurate Measurement of Mitochondrial DNA Deletion Level and Copy Number Differences in Human Skeletal Muscle , 2014, PloS one.

[7]  Vincent Procaccio,et al.  Progressive increase in mtDNA 3243A>G heteroplasmy causes abrupt transcriptional reprogramming , 2014, Proceedings of the National Academy of Sciences.

[8]  D. Ramsay,et al.  MELAS: A Multigenerational Impact of the MTTL1 A3243G MELAS Mutation , 2014, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[9]  F. Scaglia,et al.  Mitochondrial DNA Depletion Syndromes: Review and Updates of Genetic Basis, Manifestations, and Therapeutic Options , 2013, Neurotherapeutics.

[10]  S. Dimauro,et al.  Human mitochondrial DNA: roles of inherited and somatic mutations , 2012, Nature Reviews Genetics.

[11]  D. Wallace,et al.  Energetics, epigenetics, mitochondrial genetics. , 2010, Mitochondrion.

[12]  E. Shoubridge,et al.  The mitochondrial DNA genetic bottleneck results from replication of a subpopulation of genomes , 2008, Nature Genetics.

[13]  M. Tesařová,et al.  The impact of mitochondrial tRNA mutations on the amount of ATP synthase differs in the brain compared to other tissues. , 2008, Biochimica et biophysica acta.

[14]  H. Rajasimha,et al.  Selection against pathogenic mtDNA mutations in a stem cell population leads to the loss of the 3243A-->G mutation in blood. , 2008, American journal of human genetics.

[15]  K. Nihei,et al.  The mutant mitochondrial genes in mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) were selectively amplified through generations , 1992, Journal of Inherited Metabolic Disease.

[16]  K. Hayasaka,et al.  Tissue distribution of mutant mitochondrial DNA in mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) , 1993, Journal of Inherited Metabolic Disease.

[17]  K. Gerbitz,et al.  A specific point mutation in the mitochondrial genome of Caucasians with MELAS , 1991, Human Genetics.

[18]  Jean-Pierre Mazat,et al.  Mitochondrial threshold effects. , 2003, The Biochemical journal.

[19]  S. Rahman,et al.  Decrease of 3243 A-->G mtDNA mutation from blood in MELAS syndrome: a longitudinal study. , 2001, American journal of human genetics.

[20]  Y. Koga,et al.  Heterogeneous presentation in A3243G mutation in the mitochondrial tRNALeu(UUR) gene , 2000, Archives of disease in childhood.

[21]  A. Federico,et al.  Studies on mitochondrial pathogenesis of Rett syndrome: ultrastructural data from skin and muscle biopsies and mutational analysis at mtDNA nucleotides 10463 and 2835. , 1999, Journal of submicroscopic cytology and pathology.

[22]  A. Quigley,et al.  Detection of MELAS A3243G point mutation in muscle, blood and hair follicles , 1998, Journal of the Neurological Sciences.

[23]  K. Majamaa,et al.  Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population. , 1998, American journal of human genetics.

[24]  P. Matthews,et al.  Comparison of the relative levels of the 3243 (A-->G) mtDNA mutation in heteroplasmic adult and fetal tissues. , 1994, Journal of medical genetics.

[25]  S. Ohta,et al.  Content of mutant mitochondrial DNA and organ dysfunction in a patient with a MELAS subgroup of mitochondrial encephalomyopathies , 1993, Journal of the Neurological Sciences.

[26]  E. Shoubridge,et al.  Variable distribution of mutant mitochondria1 DNAs (tRNALeu[3243]) in tissues of symptomatic relatives with MELAS , 1993, Neurology.

[27]  M. Koshiba,et al.  Organ distribution of mutant mitochondrial tRNAleu(UUR) gene in a MELAS patient , 1993, Acta pathologica japonica.

[28]  S. Dimauro,et al.  Widespread tissue distribution of a tRNALeu(UUR) mutation in the mitochondrial DNA of a patient with MELAS syndrome , 1991, Neurology.

[29]  K. Gerbitz,et al.  Respiratory chain activity in tissues from patients (MELAS) with a point mutation of the mitochondrial genome [tRNALeu(UUR)] , 1991, FEBS letters.

[30]  I. Nonaka,et al.  A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies , 1990, Nature.